Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:25 PM
Ignite Modification Date:
2025-12-24 @ 4:25 PM
NCT ID:
NCT07104266
Eligibility Criteria:
Inclusion Criteria:
* Female
* Age: 18 years or older
* Tumor stage: Early
* TNBC status confirmed by pathology
* Regional lymph node N0 to N3
* No evidence of distant metastasis
* Primary tumor removed by conservative surgery with negative margins
Exclusion Criteria:
Participants will be excluded if they have experienced any of the following conditions in the last six months:
* Stomach ulcer
* Kidney disease: Glomerular filtration rate lower than 50 mL/min
* Liver disease: Aspartate aminotransferase / Alanine aminotransferase - 3 times the upper limit of normal, Bilirubine - 2 times the upper limit of normal, INR - 1.3 times the upper limit of normal, Cirrhose Child-Pugh B or more
* Congestive heart failure: Left ventricular ejection fraction lower than 50%
* Participants taking an NSAID for another medical condition or as needed before starting their radiotherapy treatment.
Participants who have demonstrated:
* Hypersensitivity to celecoxib
* A history of allergic reactions to sulfonamides
* A history of asthma attacks, urticaria, or allergic reactions after taking acetylsalicylic acid or another nonsteroidal anti-inflammatory drug
* The presence of inflammatory bowel disease
* Proven hyperkalemia
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT07104266
Study Brief:
Protocol Section:
NCT07104266